Inspire Medical Systems Stock-Based Compensation 2017-2025 | INSP
Inspire Medical Systems stock-based compensation from 2017 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
| Inspire Medical Systems Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $116 |
| 2023 | $82 |
| 2022 | $52 |
| 2021 | $26 |
| 2020 | $13 |
| 2019 | $6 |
| 2018 | $1 |
| 2017 | $0 |
| 2016 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.774B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.177B | 57.48 |
| Doximity (DOCS) | United States | $11.570B | 53.56 |
| Hims & Hers Health (HIMS) | United States | $11.189B | 116.26 |
| Tempus AI (TEM) | United States | $10.500B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.334B | 0.00 |
| Hinge Health (HNGE) | United States | $3.628B | 0.00 |
| Privia Health (PRVA) | United States | $2.525B | 172.58 |
| Enovis (ENOV) | United States | $1.763B | 9.83 |
| Schrodinger (SDGR) | United States | $1.589B | 0.00 |
| Phreesia (PHR) | United States | $1.543B | 0.00 |
| 10x Genomics (TXG) | United States | $1.533B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.532B | 0.00 |
| Azenta (AZTA) | United States | $1.470B | 68.32 |
| Evolent Health (EVH) | United States | $1.323B | 112.70 |
| Omnicell (OMCL) | United States | $1.310B | 23.12 |
| Claritev (CTEV) | United States | $0.733B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.552B | 0.00 |
| Veradigm (MDRX) | United States | $0.531B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.457B | 0.00 |
| Talkspace (TALK) | United States | $0.422B | 126.00 |
| TruBridge (TBRG) | United States | $0.328B | 728.33 |
| Outset Medical (OM) | United States | $0.312B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.282B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.261B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.250B | 0.00 |
| CapsoVision (CV) | United States | $0.218B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.152B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| Pulmonx (LUNG) | United States | $0.124B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.107B | 0.00 |
| CareCloud (CCLD) | United States | $0.105B | 3.98 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.080B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |